文献速递系统性红斑狼疮

满足2019年EULAR/ACR系统性红斑狼疮标准与损伤累积的关系

Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-06-07

研究基于LUMINA多种族多中心队列,比较随访期间满足与未满足2019年EULAR/ACR系统性红斑狼疮标准的患者结局。640例中98例从未满足标准,其末次SDI评分显著更低(1.2±1.7 vs 2.0±2.3,P=0.0004),校正后低31%(P=0.0077),生存率无统计学差异。

要点

  • 未满足2019年EULAR/ACR标准者末次SDI评分更低
  • 校正后未满足标准者SDI评分低31%(P=0.0077)
  • 两组生存率差异无统计学意义

核心结论

  • 未满足2019年EULAR/ACR标准的患者损伤累积更少,提示该标准可识别出比既往标准更严重的疾病亚组。

研究设计与样本

  • 基于LUMINA多种族多中心队列,纳入640例患者,比较随访期间满足与未满足2019年EULAR/ACR标准者的结局。
  • 采用单变量和多变量负二项回归模型,校正模型基于前向选择过程。

主要发现

  • 640例中98例从未满足2019年EULAR/ACR标准。
  • 未满足标准者与满足标准者基线平均SDI评分无差异。
  • 未满足标准者末次平均SDI评分为1.2±1.7,满足标准者为2.0±2.3(P=0.0004)。
  • 最终校正模型中,未满足标准者末次SDI评分低31%(P=0.0077)。
  • 未满足标准者生存率更高,但差异无统计学意义。

关键数值与推荐

  • 未满足标准者末次SDI评分1.2±1.7,满足标准者2.0±2.3(P=0.0004)。
  • 校正后未满足标准者末次SDI评分低31%(P=0.0077)。

临床怎么用

  • 2019年EULAR/ACR标准可用于识别损伤累积风险更高的系统性红斑狼疮患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the difference in outcomes in patients who achieved or did not achieve the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria. METHODS: Patients from the LUpus in MInorities, NAture versus nurture (LUMINA) cohort were included. For these analyses, we compared those patients who achieved the 2019 EULAR/ACR criteria any time during follow-up to those who did not. The predefined outcomes were the last Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI) scores and survival. Univariable and multivariable negative binomial regression models were performed; adjustment models were based on a forward selection process. RESULTS: In total, 98 of 640 patients never achieved the 2019 EULAR/ACR criteria. There was no difference in mean baseline SDI score among the patients who did not achieve the criteria compared to those who did. Conversely, the mean ± SD SDI score at last visit was lower for those who never achieved the criteria (1.2 ± 1.7 versus 2.0 ± 2.3, P = 0.0004). In the final adjusted model, the SDI score at last visit was 31% lower for those who never achieved the criteria (P = 0.0077). These patients were also more likely to survive, but this was not statistically significant. CONCLUSION: In our cohort, patients who did not achieve the 2019 EULAR/ACR criteria accrued less damage, suggesting that these criteria could allow us to identify a subset of patients with more severe disease than allowed by previous criteria.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Ugarte-Gil MF, Pons-Estel GJ, Griffin R, et al. Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort. Arthritis Care Res (Hoboken). 2021. PMID: 32293109. doi:10.1002/acr.24213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。